Objective
To evaluate the contribution and application of orbital fat-to-muscle ratio (FMR) in Thyroid Eye Disease related restrictive strabismus.
Design
Retrospective cross-sectional study.
Subjects, Participants
Adult patients (≥18 years) with a confirmed diagnosis of TED evaluated at a tertiary referral thyroid eye disease clinic between 2017 and 2025 who had high-resolution orbital CT imaging available for quantitative analysis.
Methods
Orbital CT scans were analyzed using three-dimensional (3D) volumetric segmentation to quantify orbital fat and extraocular muscle (EOM) volumes. The FMR was calculated for each orbit. A simplified single-slice two-dimensional (2D) FMR was also measured for comparison. Clinical data included presence and magnitude of strabismus, restrictive ocular motility, Clinical Activity Score (CAS), thyroid-stimulating immunoglobulin (TSI) levels, and surgical history. Associations were assessed using correlation analyses, multivariable logistic regression, intraclass correlation coefficients (ICC), and receiver operating characteristic (ROC) analysis.
Main Outcome Measures
Association of FMR with TED factors associated with disease severity, restrictive ocular motility and strabismus presence.
Results
Of 579 screened patients, 197 met inclusion criteria (mean age 54.9 ± 16.3 years; 69.7% female). Restrictive ocular motility was present in 39.1% and was associated with significantly lower FMR compared with nonrestrictive disease (0.69 ± 0.36 vs 0.91 ± 0.42; P <.001). Strabismus angle correlated inversely with FMR (r = −0.169; P =.030), as did the number of EOMs operated during strabismus surgery (r = −0.160; P =.027). FMR was negatively correlated with CAS (r = −0.186; P =.010) and TSI (r = −0.188; P =.047). In multivariable analysis, lower FMR remained an independent predictor of restrictive motility. An FMR cutoff of 0.66 best discriminated the presence of strabismus (sensitivity 0.59; specificity 0.72). Agreement between 2D and 3D measurements was good (ICC = 0.77).
Conclusions
Quantitative FMR derived from CT segmentation is a clinically relevant imaging biomarker in TED that reflects a continuous spectrum of muscle and fat involvement. Lower FMR identifies patients at increased risk for restrictive motility, strabismus, and inflammatory activity. Three-dimensional FMR provides superior anatomical and clinical relevance compared with 2D measurements and may enhance risk stratification and longitudinal assessment in TED.
INTRODUCTION
T hyroid eye disease (TED), also known as Graves’ orbitopathy, is an autoimmune inflammatory disorder that affects orbital tissues, including adipocytes, extraocular muscles (EOMs), fibroblasts, and connective tissue within the orbit. Clinical manifestations may include proptosis, eyelid retraction, chemosis, restrictive myopathy, compressive optic neuropathy, and strabismus.
Historically, TED has been conceptualized in 2 dichotomous radiologic phenotypes: Type 1 (fat-predominant) and Type 2 (muscle-predominant). In the classic model, Type 1 disease is characterized by adipogenesis and orbital fat expansion, leading predominantly to proptosis, while Type 2 disease is characterized by muscle enlargement and fibrosis, often resulting in restrictive strabismus, motility limitations and inflammation. However, in clinical practice, many patients do not fit neatly into one of these categories; Instead, most patients exhibit mixed phenotypes with varying contributions of fat and muscle involvement. This continuum challenges the binary classification and underscores the need for quantitative biomarkers to precisely define the balance between fat and muscle involvement.
Advances in orbital imaging and segmentation methodologies enable volumetric quantification of orbital fat and EOMs, allowing a fat-to-muscle ratio (FMR) to be measured per orbit. Quantitative segmentation allows objective measurement of volume instead of relying on two-dimensional assessments. Several studies have explored this ratio or analogous imaging indices (eg, muscle/fat indices), demonstrating associations with proptosis, disease severity, and orbital remodeling.
Strabismus in the context of TED typically result from muscle enlargement, inflammation, fibrosis, and corresponding restriction of ocular motility. It remains unclear to what extent the degree of muscle-predominance, as assessed by FMR, predicts the presence or severity of strabismus.
In this study we aimed to evaluate the association of FMR to strabismus, eye movement restriction and inflammation criteria. Our goal is to provide imaging markers that move beyond the traditional Type 1/Type 2 dichotomy, enabling clinical prediction of motility complications and inflammation in TED.
METHODS
STUDY DESIGN AND POPULATION
This is a retrospective cross-sectional study of patients with TED who were evaluated at the Sheba Medical Center Thyroid clinic between 2017 and 2025. Inclusion criteria were age ≥18 years, a confirmed diagnosis of TED, documented follow-up in the TED clinic after 2017, and availability of high-resolution orbital CT imaging suitable for quantitative analysis obtained prior to orbital decompression surgery, if decompression was subsequently performed. The scan used for quantitative analysis was the earliest high-resolution orbital CT available after the initial diagnosis of TED. Patients with prior orbital decompression or inadequate imaging quality were excluded.
CLINICAL DATA
Demographic variables (age, sex, systemic diseases and smoking status), thyroid disease–related parameters (disease duration and treatment history), and ophthalmic evaluation including the presence of strabismus, deviation angle and eye movement deficit were retrieved from the electronic medical records. Eye involvement was determined in the TED multidisciplinary Clinic by factors including exophthalmos, limitation of gaze, imaging and clinical assessment. Restrictive eye movements were defined as limitation of motility ( ) documented at orthoptics examination. The CAS score was divided into low CAS (0-2) and high (CAS (3-7), reflecting disease activity.
SEGMENTATION AND FMR
All CT scans were acquired with a slice thickness of 0.6 mm or less. Image processing and segmentation were performed at the PlanNet—3D Medical Solutions Center, Sheba Medical Center, using Mimics software (Materialize, Leuven, Belgium). Orbital boundaries were manually delineated between orbital bones ( Figure 1 ). Eyelids were excluded by submitting 4 pixels which are equal to 6 mm in average. After measuring Orbital volume, the orbital fat was measured by using Threshold-based segmentation.
Flowchart of study TED patients included in the FMR analysis.
3D Model: For each orbit, fat volume, globe volume (calculated from its diameter) and a constant optic nerve/sheath volume of 500 mm³ (calculated by orbital optic nerve length- 30 mm, mean diameter 4.8) were subtracted from the total orbital volume (serves as the numerator) to isolate extraocular muscle volume (serving as the denominator).
The 3D fat-to-muscle ratio (FMR₃D) was calculated as:
2D Model: On a standardized first coronal slice posterior to the globe, fat and muscle areas were segmented. The optic nerve was approximated as a constant 30 mm², yielding the 2D fat-to-muscle ratio (FMR₂D):
Both right and left orbits were analyzed separately. For primary analyses, the “more affected eye” (lower FMR) was designated as the study eye, while the contralateral orbit was analyzed separately as the “less affected eye.”
STATISTICAL ANALYSIS
Continuous variables were summarized as mean ± SD (SD). Categorical variables are presented as counts and percentages. Between-group comparisons used parametric or nonparametric tests as appropriate, while χ² or Fisher’s exact tests were applied for categorical outcomes. Pearson and Spearman correlation was used to examine the relationship between continuous variables. Logistic regression was applied to model binary outcomes as a function of continuous or categorical predictors. Agreement between 2D and 3D FMR measurements was assessed using the intraclass correlation coefficient (ICC, two-way mixed, absolute agreement) to evaluate whether a single slice could substitute for full volumetric segmentation. We used Youden’s J statistics, to select FMR cutoffs for presence of strabismus. Model discrimination was assessed by receiver operating characteristic (ROC) analysis, reporting the area under the curve (AUC). All analyses were performed using SPSS version 28 (IBM Corp., Armonk, NY), with statistical significance defined as P <.05.
RESULTS
Of the 579 patients screened, 197 met all inclusion criteria and were included in the analysis ( Figure 2 ). The cohort comprised of 60 men (30.3%) and 137 women (69.7%), with a mean age of 54.85 ± 16.25 years. The mean time from thyroid disorder diagnosis to TED diagnosis was 28.50 ± 64.37 months. Almost a quarter (24.4%, n = 48) reported a family history of thyroid disease.
CT with marking and segmentation—Marking orbital volume: A. coronal, B. axial, C. 3D segmentation. Marking with orbital fat: D. coronal, E. axial, F. 3D segmentation.
Comprehensive demographic and clinical characteristics are summarized in Table 1 .
TABLE 1
Demographic and Clinical Characteristics
| Characteristics | All Patients (N = 197) | |
|---|---|---|
| Age | ||
| Sex, Male | 60 (30.3%) | |
| Smoking | 72 (36.4%) | |
| Thyroid disorder duration (months) | ||
| Family history of Thyroid disorder | 48 (24.4%) | |
| Systemic diseases | ||
| Graves | 154 (78.2%) | |
| Hypertension | 47 (23.8%) | |
| Diabetes | 44 (22.3%) | |
| Heart disease | 35 (17.7%) | |
| TED Characteristics | ||
| TED duration (months) | ||
| Diplopia | 90 (45.5%) | |
| CAS | ||
| TSI level | ||
| Decompression surgery | 47 (23.8%) | |
Stay updated, free articles. Join our Telegram channel
Full access? Get Clinical Tree